EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CEZYCE was filed as Word mark on 05/03/2012 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/28/2012.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 010853554 |
| Application date | May 3, 2012 |
| Publication date | August 21, 2012 |
| Entry date | November 28, 2012 |
| Expiration date | May 3, 2022 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; pharmaceutical preparations; veterinary preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 3, 2023 | Extension, Trade mark expired | ||
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11010853554